Lantheus Holdings, Inc. Revenues
Lantheus Holdings, Inc. (LNTH) reported Revenues of $343.37 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-20.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2019-02-20
- Lantheus Holdings, Inc. revenues for the quarter ending 2018-03-31 was $82.63M, a 1.56% increase year-over-year.
- Lantheus Holdings, Inc. revenues for the quarter ending 2017-12-31 was $81.24M, a 9.27% increase year-over-year.
- Lantheus Holdings, Inc. revenues for the quarter ending 2017-09-30 was $79.94M, a 9.41% increase year-over-year.
- Lantheus Holdings, Inc. revenues for the quarter ending 2017-06-30 was $88.84M, a 13.94% increase year-over-year.
- Lantheus Holdings, Inc. revenues for fiscal 2018 was $343.37M, a 3.62% increase from fiscal 2017.
- Lantheus Holdings, Inc. revenues for fiscal 2017 was $331.38M, a 9.78% increase from fiscal 2016.
- Lantheus Holdings, Inc. revenues for fiscal 2016 was $301.85M, a 2.86% increase from fiscal 2015.
- Lantheus Holdings, Inc. revenues for fiscal 2015 was $293.46M, a 2.70% decline from fiscal 2014.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-12-31 | $343.37M 10-K · filed 2019-02-20 | |||
| 2018-03-31 | $82.63M 10-Q · filed 2018-05-02 | $163.87M derived: sum of 2 quarters · filed 2019-02-20 | $243.81M derived: sum of 3 quarters · filed 2019-02-20 | $332.65M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-12-31 | $81.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $161.18M derived: sum of 2 quarters · filed 2019-02-20 | $250.02M derived: sum of 3 quarters · filed 2019-02-20 | $331.38M 10-K · filed 2019-02-20 |
| 2017-09-30 | $79.94M 10-Q · filed 2017-11-02 | $168.78M derived: sum of 2 quarters · filed 2017-11-02 | $250.14M 10-Q · filed 2017-11-02 | $324.49M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-06-30 | $88.84M 10-Q · filed 2017-08-01 | $170.20M 10-Q · filed 2017-08-01 | $244.55M derived: sum of 3 quarters · filed 2019-02-20 | $317.61M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-03-31 | $81.36M 10-Q · filed 2018-05-02 | $155.71M derived: sum of 2 quarters · filed 2019-02-20 | $228.77M derived: sum of 3 quarters · filed 2019-02-20 | $306.74M derived: sum of 4 quarters · filed 2019-02-20 |
| 2016-12-31 | $74.35M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $147.41M derived: sum of 2 quarters · filed 2019-02-20 | $225.38M derived: sum of 3 quarters · filed 2019-02-20 | $301.85M 10-K · filed 2019-02-20 |
| 2016-09-30 | $73.06M 10-Q · filed 2017-11-02 | $151.03M derived: sum of 2 quarters · filed 2017-08-01 | $227.50M 10-Q · filed 2017-11-02 | $298.70M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $77.97M 10-Q · filed 2017-08-01 | $154.44M 10-Q · filed 2017-08-01 | $225.64M derived: sum of 3 quarters · filed 2018-02-26 | $299.76M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $76.47M 10-Q · filed 2017-05-02 | $147.68M derived: sum of 2 quarters · filed 2018-02-26 | $221.80M derived: sum of 3 quarters · filed 2018-02-26 | $295.11M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $71.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $145.32M derived: sum of 2 quarters · filed 2018-02-26 | $218.64M derived: sum of 3 quarters · filed 2018-02-26 | $293.46M 10-K · filed 2018-02-26 |
| 2015-09-30 | $74.12M 10-Q · filed 2016-11-01 | $147.44M derived: sum of 2 quarters · filed 2016-11-01 | $222.26M 10-Q · filed 2016-11-01 | $299.23M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $73.31M 10-Q · filed 2016-08-04 | $148.14M 10-Q · filed 2016-08-04 | $225.11M derived: sum of 3 quarters · filed 2017-02-23 | $300.79M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $74.82M 10-Q · filed 2016-05-03 | $151.79M derived: sum of 2 quarters · filed 2017-02-23 | $227.47M derived: sum of 3 quarters · filed 2017-02-23 | $303.09M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $76.97M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $152.65M derived: sum of 2 quarters · filed 2017-02-23 | $228.26M derived: sum of 3 quarters · filed 2017-02-23 | $301.60M 10-K · filed 2017-02-23 |
| 2014-09-30 | $75.68M 10-Q · filed 2015-11-04 | $151.29M derived: sum of 2 quarters · filed 2015-11-04 | $224.63M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $75.61M 10-Q · filed 2015-08-05 | $148.95M 10-Q · filed 2015-08-05 | ||
| 2013-12-31 | $283.67M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |